Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017420-75Phase 4Completed
Phase 4 trial of ropivacaine in postoperative pain, sponsored by Joergen B Dahl. Primary endpoint: Primary endpoint: pain score during coughing (AUC/24 hours). Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017420-75.